Fentanyl Patch Adhesive Formulation for Rapid Permeation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing fentanyl patches face issues with slow drug absorption, fluid leakage, skin irritation, and storage stability due to their reservoir-type design and the use of volatile absorption enhancers, which hinder immediate analgesic effects and long-term stability.

Innovation Solution

A fentanyl patch with a laminate structure comprising a SIS-based pressure-sensitive adhesive layer, optimized with a rosin resin and other tackifier resins, polybutene, liquid paraffin, and fatty acid esters, achieving balanced solubility, adhesiveness, and reduced irritation, with specific weight ratios of rosin resin to fentanyl and tackifier resins to enhance skin permeation and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of stationary object

If reservoir-type long-acting preparations of percutaneous absorption type are used, then blood concentration can be maintained at effective levels for 24 to 72 hours, but drug absorption is slow and immediate analgesic effect cannot be produced

Engineering Contradiction:
Improveduration of effective blood concentrationVSAvoidspeed of drug absorption
Core Design Contradiction:
Duration of action of stationary objectVSSpeed

Solution Approach 1:

The patent divides the single-layer reservoir structure into multiple layers: a rate-controlling membrane layer with micropores for gradual drug release, and a reservoir layer for drug storage. This segmentation allows simultaneous achievement of rapid initial absorption through the membrane and sustained release over 24-72 hours from the reservoir.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent changes the physical parameters of the rate-controlling membrane by adjusting pore size (0.01-10 μm), porosity (10-80%), and thickness (1-100 μm) to optimize the balance between rapid initial drug permeation and sustained release duration, achieving both fast absorption and long-lasting effect.

Inventive Principle:
Principle #35Parameter changes

2Duration of action of stationary object

If reservoir-type preparations are used, then prolonged drug delivery is achieved, but fluid leakage occurs

Engineering Contradiction:
Improveduration of drug deliveryVSAvoidfluid leakage prevention
Core Design Contradiction:
Duration of action of stationary objectVSReliability

Solution Approach 1:

The patent employs a flexible rate-controlling membrane made of polymer materials (such as ethyl cellulose, polyvinylidene chloride) with controlled porosity that acts as a barrier to prevent fluid leakage while allowing drug molecules to pass through, maintaining reliable sealed delivery over 24-72 hours.

Inventive Principle:
Principle #30Flexible shells and thin films

3Quantity of substance

If ethanol is used in reservoir-type preparations, then drug solubility is improved, but strong skin irritation occurs at the application site

Engineering Contradiction:
Improvedrug solubilityVSAvoidskin irritation
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and removes ethanol from the formulation, replacing it with alternative solvents or solvent-free matrix systems that maintain drug solubility without causing skin irritation, thereby eliminating the harmful effect while preserving the beneficial solubility property.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces intermediate substances such as fatty acids, esters, or surfactants that act as mediators to enhance drug solubility in the adhesive matrix without requiring ethanol, thus achieving solubility improvement without skin irritation.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Force

If acrylic adhesive is used as main base in matrix-type patches, then skin adhesion is improved, but drug-release is inferior requiring increased main drug content

Engineering Contradiction:
Improveskin adhesion strengthVSAvoiddrug-release efficiency
Core Design Contradiction:
ForceVSProductivity

Solution Approach 1:

The patent uses composite adhesive systems combining acrylic adhesive with other polymers or plasticizers in specific ratios to maintain strong skin adhesion while improving drug diffusion pathways, thereby enhancing drug-release efficiency without increasing total drug content.

Inventive Principle:
Principle #40Composite materials

5Productivity

If increased main drug content is used to achieve desired drug-release with acrylic adhesive, then drug-release level is improved, but crystallization during storage and residual fentanyl after application occur

Engineering Contradiction:
Improvedrug-release levelVSAvoidstorage stability
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent changes the physical state and distribution parameters of fentanyl in the adhesive matrix by controlling concentration, temperature, and solvent evaporation rates during manufacturing, preventing crystallization during storage while maintaining adequate drug-release levels through optimized formulation rather than simply increasing drug content.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The patch provides rapid and sustained fentanyl permeation through the skin, high storage stability, and reduced skin irritation, maintaining effective blood concentrations with improved adhesiveness and preventing drug crystallization.

Implementation Method 1

preparations for percutaneous absorption in which an acrylic adhesive is used as a main base

Methodology Applied
Scientific EffectPercutaneous absorption: Permeation

Implementation Method 2

the drug absorption after application thereof is fairly slow and the blood concentration arrives at an effective level

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 3

a SIS-based pressure-sensitive adhesive layer containing a tackifier resin consisting of a rosin resin and at least one other tackifier resin

Methodology Applied
Scientific EffectAdhesion: Adhesive

Implementation Method 4

N-methyl-2-pyrrolidone, for instance, used as an absorption enhancer in a SIS-based preparation has the effect of reducing the period of delay in percutaneous absorption

Methodology Applied
Scientific EffectAbsorption enhancement: Permeation

Implementation Method 5

since, however, N-methyl-2-pyrrolidone is volatile, there arises a problem: namely, N-methyl-2-pyrrolidone may evaporate during storage and/or application, possibly resulting in changes in drug-release

Methodology Applied
Scientific EffectEvaporation: Evaporation

Implementation Method 6

The increase in the main drug content causes other problems, for example the problem of crystallization of the main drug during storage

Methodology Applied
Scientific EffectCrystallization prevention: Crystallisation

Data Source

PatentUS10376474B2Fentanyl-containing patch for external use
Publication Date: 2019.08.13 TEIKOKU SEIYAKU CO LTD
  • US10376474B2 patent drawing

AI summary

A patch for external use which has a laminate structure comprising a substrate and a pressure-sensitive adhesive layer which contains a styrene/isoprene/styrene block copolymer as the base and further contains a tackifier resin consisting of a rosin resin and at least one other tackifier resin, a softening agent consisting of polybutene and liquid paraffin, a fatty acid ester, and fentanyl, characterized in that the weight ratio of the rosin resin to fentanyl is 1 to 5, the weight ratio of the rosin resin to the whole tackifier resin is 0.1 to 0.6, and the tackifier resin accounts for 30 to 60 wt % of the whole pressure-sensitive adhesive layer. The patch is excellent in the permeation of fentanyl through the skin and in storage stability, and is weak in irritation to skin.